ABSTRACT.
Objectives: cerebral aspergillosis is a rare but often fatal form of invasive aspergillosis that remains difficult to diagnose. The literature has shown the value of Aspergillus PCR in bloodderived samples for the diagnosis of invasive aspergillosis but provides far less information for cerebrospinal fluid (CSF) in cerebral aspergillosis. Here, we evaluated the usefulness of an Aspergillus PCR assay performed on CSF for the diagnosis of cerebral aspergillosis.
Methods: this retrospective study involved 72 patients with suspected cerebral aspergillosis for a total of 88 CSF samples in whom CSF Aspergillus PCR was performed.
Results: seventeen patients had proven/probable invasive aspergillosis according to the European Organisation for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria, including twelve cases of proven/probable cerebral aspergillosis.
Aspergillus PCR in CSF was positive in nine of the twelve patients with cerebral aspergillosis, i.e. 75% sensitivity. In contrast, CSF culture was positive for Aspergillus in only two patients. In the non cerebral aspergillosis group (60 patients), PCR was positive in one patient, i.e., 98.3% specificity. In this particular population of high-risk patients with suspicion of cerebral aspergillosis, the disease incidence was 16.7%. Therefore, the positive and negative predictive values of PCR were 90% and 95.2% respectively.
Conclusion: the results of this study indicate that Aspergillus PCR in CSF is an interesting tool that may eliminate the need for cerebral biopsy in patients with suspected cerebral aspergillosis.
INTRODUCTION.
Cerebral aspergillosis (CA) is a rare clinical form of invasive aspergillosis with a mortality rate of up to 90% [1], whose diagnosis remains challenging to this day [2, 3] . Indeed, the diagnostic gold standard relies on histopathological examination of brain tissue biopsies which are rarely performed. Imaging studies, especially magnetic resonance imaging (MRI), can be helpful. Cerebral abscesses and aneurysms are the main characteristics found during CA but these findings are not specific and depend on the mode of dissemination of the infection [4] . Cerebrospinal fluid (CSF) stands as an alternative. It can be subjected to the same tests used in blood-derived samples or in bronchoalveolar lavage samples (BAL) to diagnose invasive aspergillosis, such as culturing, galactomannan determination or PCR.
Several studies have shown the utility of galactomannan determination in CSF for the diagnosis of CA, but few were focused on the performance of Aspergillus PCR despite its demonstrated value for the diagnosis of invasive aspergillosis when performed on bloodderived samples [5, 6] . In the few studies that have looked at Aspergillus PCR in CSF, the technique yielded excellent sensitivity and specificity, up to 100% and 93% respectively, but those data need confirmation due to the small number of patients included in the studies [7, 8] . Thus, for the present study, we sought to enlarge this knowledge base by evaluating the performance of an in-house A. fumigatus real-time PCR using CSF from patients with suspected cerebral aspergillosis.
MATERIALS AND METHODS.
This retrospective single-centre analysis was performed between February 2012 and January 2016 in La Pitié Salpêtrière hospital, a tertiary care centre in Paris, France. As the study was performed using results get from routine clinical practice, any authorization from a research ethics committee was not required. Patients in whom a CSF Aspergillus PCR was prescribed by clinicians were considered to have a suspected CA and were included in the study. If clinical or radiological data were lacking we thereafter excluded these patients from analyses.
CA was defined as proven when patients had a positive Aspergillus culture in CSF or brain biopsy tissue. It was defined as probable when patients had cerebral radiological findings suggestive of the diagnosis (e.g. cerebral abscess, meningeal enhancement or vasculitis) and a proven or probable invasive aspergillosis elsewhere, as previously reported [9] . Patients were diagnosed as no CA when they had no invasive aspergillosis, or had invasive aspergillosis with cerebral abnormalities due to another aetiology.
We used a real-time PCR that targets a previously-described 67-bp segment of a 28S ribosomal RNA coding DNA [5, 10] . Extraction, amplification and quantification were performed as previously described [11] , excepted if CSF volume was below 1 mL. In that case, the totality of the CSF sample was centrifuged and DNA extraction was performed on 200 µL of the centrifugation pellet, using the extractions columns of the QIAamp DNA Blood Mini Kit (Qiagen).
RESULTS.
Over the study period, PCR was performed in 86 patients and clinical and radiological data were available for 72 patients (88 CSF samples). Diagnosis of proven or probable CA was made for five and seven patients, respectively. Among them, 8 patients suffered from CA with additional organ involvement and four had only an isolated CA. Finally, 5 patients suffered from proven/probable invasive aspergillosis but without CA (Figure 1) . Incidence of CA in this at-risk population was 16.7% (12/72).
Clinical and radiological findings of patients suffering from CA are shown in Table S1 .
CSF Aspergillus PCR was positive in nine of the 12 patients with CA, leading to a sensitivity of 75% (95% confidence interval [CI], 62.5-87.5%) ( Four biopsy specimens were also positive for A. fumigatus, thus establishing a proven diagnosis. CSF PCR was positive for three of these four biopsy-proven cases and negative for one (this latter having also a negative galactomannan index and a negative mycological culture of CSF).
Of the 60 patients without CA, only one had a positive PCR in CSF and all CSF cultures were negative. Considering these results, the specificity, the positive predictive value and the negative predictive value of the A. fumigatus PCR in CSF were 98.3% (95% CI, 95.5-100% ), 90% (95% CI, 71.5-100%) and 95.2% (95% CI, 89.9-100%) respectively.
Positive and negative likelihood ratio were 45 (95% CI, 6.27-323) and 0.254 (95% CI, 0.10-0.68) respectively, and diagnosis odds ratio was 177 (95% CI, 16-1892).
DISCUSSION.
In this study we found that Aspergillus PCR in CSF is a useful tool for the diagnosis of CA.
In this setting, it provided 75% sensitivity, a rate comparable with its performance in bloodderived samples [5, 6] . Specificity, PPV and NPV were very good in our study, respectively 98.3%, 90% and 95.2%. CA is a rare but severe infection associated with a high mortality rate [1] . Early initiation of antifungal therapy may improve the prognosis, but this is hampered by the diagnosis, which remains a challenge in current practice. Therefore, mycological tools have been proposed for use in CSF. Galactomannan index determination and mycological culture of CSF have been recognised within the EORTC/MSG criteria for the diagnosis of CA [12] . Aspergillus PCR, although it has shown its value for the diagnosis of invasive aspergillosis in blood-derived samples, has not yet been included in the EORTC/MSG criteria and expert recommendations for its use carry precautions [13] . In our study, CSF PCR greatly outperformed mycological culture, the latter being positive in only two patients (16.7%). Direct evidence of fungal elements in CSF using a silver staining approach was not observed. Although mycological examination of cerebral biopsy tissue was very useful, it was available for only four patients. However, among those four patients, three had positive CSF PCRs, suggesting that PCR could be used as a substitute for particularly invasive and sometimes unattainable brain biopsies. Unfortunately, we were not able to fully compare the performances of PCR to that of the galactomannan index determination because it was determined in only 5 patients.
Because of the small number of cerebral aspergillosis cases, few studies have evaluated the performances of Aspergillus PCR in CSF. Although in this study cases were also limited, we nonetheless report one of the largest series of cerebral aspergillosis cases, and to our knowledge, the largest series with PCR results. Reinwald et al previously reported a sensitivity of 100% for PCR in CSF [8] . However, their study comprised only eight cases and employed a nested PCR that can lead to more false-positive results (specificity was 93% in their study) [14] . In our study, the 3 CSF PCR negative results, leading to a comparatively lower sensitivity, may be explained in part by one case of probable CA due to A. niger, a species not recognised by our PCR. The 2 other negative PCR results were found in 2 patients suffering from only cerebral abscesses without associated meningitis (0 and 1 white blood cell in CSF), that can also explain a negative result in CSF.
In conclusion, the results of this study indicate that performing Aspergillus PCR in CSF is an interesting tool for the diagnosis of cerebral aspergillosis and potentially a substitute for invasive cerebral abscess punctures. However, prospective multicentre studies are needed to confirm these results in the largest possible population, and to compare the performance of PCR with that of the galactomannan index when performed on CSF.
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